Taking aspirin or ibuprofen reduces bowel cancer risk for Lynch syndrome patients

on June 27, 2015

Their research is the first to validate findings that aspirin has a protective effect against bowel cancer in these patients. They also showed for the first time that patients with Lynch Syndrome who took ibuprofen were about 60% less likely to develop bowel cancer compared to those that didn’t take ibuprofen. This is important as people with Lynch syndrome have a much higher risk of developing bowel cancer. These results are part of the largest multi-national study to investigate the link between common painkillers and bowel cancer risk.

Read more about these findings.